We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
View All

Blog - Pharmaceutical Products

Goldman Sachs Asset Management Set to Acquire Synthon International from BC Partners
Goldman Sachs Asset Management Set to Acquire Synthon International from BC Partners
Dec 15, 2024
Eye 426

Goldman Sachs Asset Management is close to acquiring Synthon International from BC Partners for around EUR2 billion, highlighting the growing interest in the pharmaceutical industry.
Novo Holdings to Finalize $16.5 Billion Acquisition of Catalent
Novo Holdings to Finalize $16.5 Billion Acquisition of Catalent
Dec 14, 2024
Eye 188

Novo Holdings finalizes $16.5 billion acquisition of Catalent, enhancing pharmaceutical capabilities amidst regulatory clearance.
Novo Nordisk's Ozempic: Recent Study Reveals Potential Risk of Rare Vision Loss
Novo Nordisk's Ozempic: Recent Study Reveals Potential Risk of Rare Vision Loss
Dec 13, 2024
Eye 163

Recent research suggests a potential link between Novo Nordisk's Ozempic and a rare vision impairment, NAION, urging patients to weigh therapeutic benefits against potential risks.
Global Private Equity Giants Vie for Mitsubishi Tanabe Pharma
Global Private Equity Giants Vie for Mitsubishi Tanabe Pharma
Dec 13, 2024
Eye 184

Leading private equity firms Blackstone and Bain Capital, along with Japan Industrial Partners, are vying to acquire Mitsubishi Tanabe Pharma. The deal, potentially valued at $3 billion to $3.5 billion, marks a significant event in the pharmaceutical investment landscape.
Grifols Faces a Challenging Year Amid Investor Concerns and Strategic Shifts
Grifols Faces a Challenging Year Amid Investor Concerns and Strategic Shifts
Dec 13, 2024
Eye 98

Spanish drugmaker Grifols SA navigates a challenging year with strategic shifts and investor concerns, aiming to stabilize financially and regain market confidence.
Ro and Eli Lilly Join Forces to Make Zepbound Vials Affordable
Ro and Eli Lilly Join Forces to Make Zepbound Vials Affordable
Dec 11, 2024
Eye 270

Ro collaborates with Eli Lilly to offer affordable Zepbound vials, enhancing weight loss drug accessibility and affordability.
Vitamin Imports in South Africa Drop by 21% to Reach $53 Million in 2023
Vitamin Imports in South Africa Drop by 21% to Reach $53 Million in 2023
Dec 8, 2024
Eye 125

During the review period, Vitamin imports reached a peak of 6.8K tons in 2021, but decreased in the following years. In terms of value, Vitamin imports dropped significantly to $53M in 2023.
Top Import Markets for Medicaments Containing Vitamins
Top Import Markets for Medicaments Containing Vitamins
Dec 7, 2024
Eye 122

Discover the top import markets for medicaments containing vitamins and the key statistics from the IndexBox market intelligence platform.
Spain Sees 18% Increase, Bringing Biological Product Imports to $4.8 Billion in 2023
Spain Sees 18% Increase, Bringing Biological Product Imports to $4.8 Billion in 2023
Dec 5, 2024
Eye 85

From 2022 to 2023, the growth of imports for Biological Product remained somewhat lower, reaching a value of $4.8B in 2023.
Novavax to Divest Czech Facility to Novo Nordisk for $200 Million
Novavax to Divest Czech Facility to Novo Nordisk for $200 Million
Dec 4, 2024
Eye 412

Novavax sells its Czech manufacturing facility to Novo Nordisk for $200 million, focusing on strengthening its vaccine pipeline and operational efficiency.
Italy's 2023 Antibiotic Imports Fall to $1.1 Billion
Italy's 2023 Antibiotic Imports Fall to $1.1 Billion
Nov 17, 2024
Eye 155

Antibiotic imports peaked at 7.2K tons in 2013 but failed to regain momentum from 2014 to 2023, with imports declining to $1.1B in value terms.
Japan's Vitamin Import Drops Significantly to $211 Million in 2023
Japan's Vitamin Import Drops Significantly to $211 Million in 2023
Nov 7, 2024
Eye 100

Imports of Vitamin peaked at 23K tons in 2022 before decreasing in the following year. In terms of value, vitamin imports declined to $211M in 2023.
Show more